Review Article Online Publishing Date: | ||||||||||||
HORMONE THERAPY IN ADVANCED ER+/HER2- NEGATIVE BREAST CANCER WITH PI3K INHIBITORS: A REVIEW OF THE LITERATURE Ivan Inkov, Desislava Penkova, George Baytchev, Zdravko Kamenov, Mila Kayryakova, Dimo Manov.
|
This Article Cited By the following articles
New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells Bioorganic Chemistry 2021; 115(): 105208. | 1 |
How to Cite this Article |
Pubmed Style Ivan Inkov, Desislava Penkova, George Baytchev, Zdravko Kamenov, Mila Kayryakova, Dimo Manov. HORMONE THERAPY IN ADVANCED ER+/HER2- NEGATIVE BREAST CANCER WITH PI3K INHIBITORS: A REVIEW OF THE LITERATURE. Int J Surg Med. 2016; 2(2): 68-76. doi:10.5455/ijsm.pi3kinhibitorbreastcancer Web Style Ivan Inkov, Desislava Penkova, George Baytchev, Zdravko Kamenov, Mila Kayryakova, Dimo Manov. HORMONE THERAPY IN ADVANCED ER+/HER2- NEGATIVE BREAST CANCER WITH PI3K INHIBITORS: A REVIEW OF THE LITERATURE. https://www.ejos.org/?mno=227219 [Access: February 20, 2024]. doi:10.5455/ijsm.pi3kinhibitorbreastcancer AMA (American Medical Association) Style Ivan Inkov, Desislava Penkova, George Baytchev, Zdravko Kamenov, Mila Kayryakova, Dimo Manov. HORMONE THERAPY IN ADVANCED ER+/HER2- NEGATIVE BREAST CANCER WITH PI3K INHIBITORS: A REVIEW OF THE LITERATURE. Int J Surg Med. 2016; 2(2): 68-76. doi:10.5455/ijsm.pi3kinhibitorbreastcancer Vancouver/ICMJE Style Ivan Inkov, Desislava Penkova, George Baytchev, Zdravko Kamenov, Mila Kayryakova, Dimo Manov. HORMONE THERAPY IN ADVANCED ER+/HER2- NEGATIVE BREAST CANCER WITH PI3K INHIBITORS: A REVIEW OF THE LITERATURE. Int J Surg Med. (2016), [cited February 20, 2024]; 2(2): 68-76. doi:10.5455/ijsm.pi3kinhibitorbreastcancer Harvard Style Ivan Inkov, Desislava Penkova, George Baytchev, Zdravko Kamenov, Mila Kayryakova, Dimo Manov (2016) HORMONE THERAPY IN ADVANCED ER+/HER2- NEGATIVE BREAST CANCER WITH PI3K INHIBITORS: A REVIEW OF THE LITERATURE. Int J Surg Med, 2 (2), 68-76. doi:10.5455/ijsm.pi3kinhibitorbreastcancer Turabian Style Ivan Inkov, Desislava Penkova, George Baytchev, Zdravko Kamenov, Mila Kayryakova, Dimo Manov. 2016. HORMONE THERAPY IN ADVANCED ER+/HER2- NEGATIVE BREAST CANCER WITH PI3K INHIBITORS: A REVIEW OF THE LITERATURE. International Journal of Surgery and Medicine, 2 (2), 68-76. doi:10.5455/ijsm.pi3kinhibitorbreastcancer Chicago Style Ivan Inkov, Desislava Penkova, George Baytchev, Zdravko Kamenov, Mila Kayryakova, Dimo Manov. "HORMONE THERAPY IN ADVANCED ER+/HER2- NEGATIVE BREAST CANCER WITH PI3K INHIBITORS: A REVIEW OF THE LITERATURE." International Journal of Surgery and Medicine 2 (2016), 68-76. doi:10.5455/ijsm.pi3kinhibitorbreastcancer MLA (The Modern Language Association) Style Ivan Inkov, Desislava Penkova, George Baytchev, Zdravko Kamenov, Mila Kayryakova, Dimo Manov. "HORMONE THERAPY IN ADVANCED ER+/HER2- NEGATIVE BREAST CANCER WITH PI3K INHIBITORS: A REVIEW OF THE LITERATURE." International Journal of Surgery and Medicine 2.2 (2016), 68-76. Print. doi:10.5455/ijsm.pi3kinhibitorbreastcancer APA (American Psychological Association) Style Ivan Inkov, Desislava Penkova, George Baytchev, Zdravko Kamenov, Mila Kayryakova, Dimo Manov (2016) HORMONE THERAPY IN ADVANCED ER+/HER2- NEGATIVE BREAST CANCER WITH PI3K INHIBITORS: A REVIEW OF THE LITERATURE. International Journal of Surgery and Medicine, 2 (2), 68-76. doi:10.5455/ijsm.pi3kinhibitorbreastcancer |